Cart
sales@molnova.com
Teriflunomide(b)
CAS No. 163451-81-8
Teriflunomide(b) ( A 77-1726 )
Catalog No. M20895 CAS No. 163451-81-8
Teriflunomide is the principal active metabolite of leflunomide?an approved therapy for rheumatoid arthritis and?multiple sclerosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 41 | Get Quote |
|
| 50MG | 52 | Get Quote |
|
| 100MG | 81 | Get Quote |
|
| 500MG | 133 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTeriflunomide(b)
-
NoteResearch use only not for human use.
-
Brief DescriptionTeriflunomide is the principal active metabolite of leflunomide?an approved therapy for rheumatoid arthritis and?multiple sclerosis.
-
DescriptionTeriflunomide is the principal active metabolite of leflunomide?an approved therapy for rheumatoid arthritis and?multiple sclerosis.
-
SynonymsA 77-1726
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indicationmultiple sclerosis (MS)
Chemical Information
-
CAS Number163451-81-8
-
Formula Weight270.21
-
Molecular FormulaC12H9F3N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:26 mg/mL (96.22 mM)
-
SMILESC/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Paul O Oh . An update of teriflunomide for treatment of multiple sclerosis[J]. Therapeutics and Clinical Risk Management 2013:177-.
molnova catalog
related products
-
Examorelin
Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?
-
Dihydroxyfumaric aci...
Dihydroxyfumaric acid can induce lipid peroxidation in rat liver microsomes.
-
F1324 acetate
F1324 acetate is an efficient, high-affinity b-cell lymphoma inhibitor with IC50 of 1 nM.
